Assess the Safety and Pharmacokinetics of Ascending, Multiple Oral Doses of SPD489 in Adults With Schizophrenia

Authors
Category Primary study
Registry of Trialsclinicaltrials.gov
Year 2011
This is a multiple ascending dose study; the purpose of this study is to examine the safety, tolerability and pharmacokinetics (levels of drug in the blood) of SPD489 in Schizophrenic Patients who are currently maintained on a stable dose of an antipsychotic medication.
Epistemonikos ID: ad06bbcb63831809683ece0d7d4a0eedfc69c044
First added on: May 10, 2024